<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="other" xml:lang="EN"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Oncol</journal-id><journal-id journal-id-type="publisher-id">JO</journal-id><journal-title>Journal of Oncology</journal-title><issn pub-type="ppub">1687-8450</issn><issn pub-type="epub">1687-8469</issn><publisher><publisher-name>Hindawi Publishing Corporation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">19277105</article-id><article-id pub-id-type="pmc">2648642</article-id><article-id pub-id-type="doi">10.1155/2008/389394</article-id><article-categories><subj-group subj-group-type="heading"><subject>Clinical Study</subject></subj-group></article-categories><title-group><article-title>Esophageal Carcinoma Histology Affects Perioperative Morbidity Following Open Esophagogastrectomy</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Woodall</surname><given-names>Charles E.</given-names></name><xref ref-type="aff" rid="I1"/></contrib><contrib contrib-type="author"><name><surname>Duvall</surname><given-names>Ryan</given-names></name><xref ref-type="aff" rid="I1"/></contrib><contrib contrib-type="author"><name><surname>Scoggins</surname><given-names>Charles R.</given-names></name><xref ref-type="aff" rid="I1"/></contrib><contrib contrib-type="author"><name><surname>McMasters</surname><given-names>Kelly M.</given-names></name><xref ref-type="aff" rid="I1"/></contrib><contrib contrib-type="author"><name><surname>Martin</surname><given-names>Robert C. G.</given-names></name><xref ref-type="aff" rid="I1"/><xref ref-type="corresp" rid="cor1">*</xref></contrib></contrib-group><aff id="I1">Division of Surgical Oncology, Department of Surgery, James Graham Brown Cancer Center, University of Louisville School of Medicine, Louisville, KY 40292, USA</aff><author-notes><corresp id="cor1">*Robert C. G. Martin: <email>robert.martin@louisville.edu</email></corresp><fn fn-type="other"><p>Recommended by Bruce Baguley</p></fn></author-notes><pub-date pub-type="ppub"><year>2008</year></pub-date><pub-date pub-type="epub"><day>5</day><month>2</month><year>2009</year></pub-date><volume>2008</volume><elocation-id>389394</elocation-id><history><date date-type="received"><day>30</day><month>5</month><year>2008</year></date><date date-type="rev-recd"><day>17</day><month>10</month><year>2008</year></date><date date-type="accepted"><day>27</day><month>11</month><year>2008</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2008 Charles E. Woodall et al.</copyright-statement><copyright-year>2008</copyright-year><license license-type="open-access"><p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></license></permissions><abstract><p>					<italic>Background</italic>. Esophagectomy for esophageal cancer is being practiced routinely with favorable results at many centers. We sought to determine if tumor histology is a powerful surrogate marker for perioperative morbidity. <italic>Methods</italic>. Seventy three consecutive patients managed operatively were reviewed from our prospectively maintained database. <italic>Results</italic>. Adenocarcinoma (AC) was present in 52 (71%) and squamous cell (SCC) in 21 (29%). The use of neoadjuvant therapy was similar for the AC (34.62%) and SCC (42.86%) groups. The SCC group had a higher incidence of prior pulmonary disease than the AC group (23.8% versus 5.8%, resp.; <italic>P</italic> = .03). SCC patients were more likely to have a prolonged ICU stay than AC patients (<italic>P</italic> = .004) despite similar complication rates, EBL, and prognostic nutritional index. The SCC group did, however, experience higher grades of complications (<italic>P</italic> = .0053). <italic>Conclusions</italic>. Presence of SCC was the single best predictor of prolonged ICU stay and more severe complications as defined by this study. Only a past history of pulmonary disease was different between the two histologic subgroups.</p></abstract></article-meta></front><body><sec sec-type="section" id="sec1"><title>1. Introduction</title><p>Esophagectomy foresophageal cancer is being practiced routinely with favorable results at manycenters. Improvements in surgical technique and perioperative care have permitted a procedure onceassociated with high mortality rates to now be practiced with a low risk ofpostoperative death. However, studies continue to report high morbidity andthere is now a focused effort to identify factors that may predictperioperative outcome.</p><p>Pulmonary complications are a majorcontributor to mortality in esophageal cancer and efforts to improve pulmonaryhygiene have contributed to reduced perioperative mortality [<xref ref-type="bibr" rid="B1">1</xref>]. As an adjunct to further decrease thesecomplications, the necessity of a thoracic incision when performingesophagectomy has long been debated. Proponents have often argued that its use enables a more complete lymphadenectomy,while opponents feel it contributes significantly to perioperative morbiditybut this has not been shown to affect long-term prognosis [<xref ref-type="bibr" rid="B2">2</xref>].</p><p>Given the importance ofpulmonary status on outcome, the ability to predict those patients at higherrisk for pulmonary complications might then be of some benefit, not only inpredicting their potential for morbidity, but also in choosing the approach that maymitigate these risks. Many feelthat a minimally invasive approach may be the answer.  Recently, investigators have reportedpromising results with minimally invasive approaches [<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B4">4</xref>]. While there is little debate regarding therole of surgical technique and comorbid conditions on the development ofpostoperative complications, little is known about the impact of tumor biologyon morbidity. Based on recent a report suggesting that the esophagealhistology may impact perioperative outcome [<xref ref-type="bibr" rid="B5">5</xref>], we sought to furtherdelineate this relationship. This study is anattempt to recognize that tumor histology alone can identify patients morelikely to suffer a complication and perhaps guide perioperative decisionmaking.</p></sec><sec sec-type="section" id="sec2"><title>2. Methods</title><p>The records of patients included in aprospectively maintained upper gastrointestinal malignancy database werereviewed for this institutional review board approved study. All patientsundergoing esophagogastrectomy for esophageal carcinoma were included in thestudy, and all patients underwent a standard combined thoracic and abdominalesophagogastrectomy (Ivor-Lewis type) procedure. This review was performedunder an IRB approved protocol from the University of Louisville Human Subjects Protection Office. All patients had undergone complete preoperative evaluation with CT chest/abdomen/ pelvis, endoscopic ultrasound, and in some, PET scanning.  Most patients with preoperative T2 or greater, or N1 (by imaging) were given neoadjuvant chemoradiation with either 5-fluorouracil or combined 5 fluorouracil withcisplatin depending on the histology of the disease and standard radiationtherapy dosing of 5040 cGy. Operative techniques were consistent across thisstudy with the esophagogastrectomy performed through an abdominal incisionfirst, with mobilization, celiac and supraceliac lymphadenectomy, pyloroplasty,and gastric conduit formation followed by a thoracic incision, withmobilization, thoracic lymphadenectomy, tumor resection, and thoracicanastomosis.</p><p>Variables evaluated included demographics(age, race, and gender), smoking history, alcohol history, histology, cancerstaging, grade and type of complications, nutritional status, length ofintensive care unit stay, and operative factors including estimated blood loss. Comorbidities, such as prior cardiac and pulmonary disease as well as historyof tobacco and alcohol abuse as reported by the patient were alsorecorded.  The prognostic nutritional index (PNI) advocated byOnodera et al. [<xref ref-type="bibr" rid="B6">6</xref>] was calculated to investigate the preoperative nutritionalcondition of the patients in both groups. It is calculated from the formula(giving a percentage) (10 &#x000d7; Albumin) + (0.005 &#x000d7; absolute lymphocyte count). Priorcardiac history was defined as any patient with a history of angina, previouscoronary artery disease defined by cardiac catheterization, previous myocardialinfarction, cardiac valve dysfunction requiring medication, or a history ofcongestive heart failure or tachyarrhythmia. Prior pulmonary disease historywas defined as any patient with abnormal pulmonary function tests, history ofasthma requiring daily meter dosed inhalers, or tobacco use greater than a 25-packyear history.</p><p>All postoperativecomplications and the length of hospital stay were prospectively entered intothe database. Complications wereidentified prospectively and assigned a grade from 1 to 5 based on anestablished scale [<xref ref-type="bibr" rid="B7">7</xref>]. Examples of the grading of complicationsincludes (1) uncomplicated urinary tract infection; (3) small, containedanastomotic leak requiring no further operative therapy or drainage procedures;(5) death.  In instances where thegrading was unclear, a score was assigned after review of the records anddiscussion between two of the senior authors. All in hospital and 90-daypostoperative complications were evaluated with the most severe complication levelrecorded. Infectious complications were defined by a positive fluid (sputum,wound, urine, etc.) culture, with some criteria of a systemic inflammatoryresponse (i.e., tachycardia, fever, and hypoxia)</p><p>Statistical analysis was performed with JMPsoftware (SAS Institute, Cary, NC, USA). Analysis of variance, log-rank analysis, and Pearson correlation coefficient wereused to determine significance, and a <italic>P</italic>-value &#x0003c;.05 was consideredsignificant in this study.</p></sec><sec sec-type="section" id="sec3"><title>3. Results</title><p>Seventy threeconsecutive patients undergoing combined abdominal and thoracicesophagogastrectomy for cancer were identified and included in the study, witha median age was 61 (range 26 to 80). 55 (75.3%) were male and 18 female(24.7%).  Fifty four patients (74%) wereCaucasian, 12 (16%) were African-American, and the race of 7 (9%) was notrecorded. There were 3 (4.1%) perioperative deaths, all occurring in the ACgroup. Adenocarcinoma (AC) was present in 52 (71%) and squamous cell (SCC) in21 (29%).  In Caucasians, AC occurredmore often than SCC (84% versus 47%, resp.; <italic>P</italic> = .004). Adenocarcinoma wasalso much more common in males (86%) than SCC (47%; <italic>P</italic> = .0007). The ACpatients were slightly younger (59 versus 63) than those in the SCC group (<italic>P</italic> = .21)(<xref ref-type="table" rid="tab1">Table 1</xref>).</p><p>Patients in the SCCgroup were significantly more likely to have a history of alcohol abuse (8/21,38.1%) versus those in the AC group (6/52, 11.5%; <italic>P</italic> = .012). They werealso more likely to have a history of pulmonary disease (asthma, COPD,pneumonia) than the AC group (23.8% versus 5.77%; <italic>P</italic> = .034). Interestingly, there was no difference in the rate of COPD between the twogroups (2.8% versus 3.9%; <italic>P</italic> = .133) and no difference in rates of tobaccouse (61.9% versus 69.2%; <italic>P</italic> = .5492), mean pack years (56.6% versus 51.0%; <italic>P</italic> = .573),or prior cardiac disease history (CAD, atrial fibrillation, prior MI, orpercutaneous coronary intervention (PCI); 19.1% versus 25.1%; <italic>P</italic> = .5806). At the time of operation, median estimated blood loss was similar for bothgroups (551 mL for AC and 600 mL for SCC, <italic>P</italic> = .7626).</p><p>In the AC group, there were two (3.9%)patients with in situ disease, five (9.8%) with T0 disease, five (9.8%) T1s, 10(19.6%) T2s, 27 (52.9%) with T3 disease, and 2 (3.9%) with T4 disease on finalpathology (<xref ref-type="table" rid="tab2">Table 2</xref>). The SCC group had a similar distribution: 2 (9.5%) T0s, 4 (19.0%) T1s, 2 (9.5%) T2s, 9 (42.8%) T3s, and 4 (19.1%) T4s; the differenceswere not significant (<italic>P</italic> = .2). Nodal staging for the AC group consisted of24 patients (47%) with N0 disease, 25 (49%) with N1 disease, and 2 (3.9%)patients with N2 disease. In the SCC group, there were 14 (66.7%) with N0disease and 7 (33.3%) with N1 disease. There were no patients with N2 diseasein the SCC group. The differences were not statistically significant (<italic>P</italic> = .25). Metastatic disease was found in one patient in each group (<italic>P</italic> = .5).</p><p>The use of neoadjuvant chemoradiation betweenthe AC and SCC groups was similar. Overall, 36% of patients receivedpreoperative therapy: 18 (34%) of the AC group and 9 (42%) of the SCC group (<italic>P</italic> = .5). A similar proportion of patients in each group had experienced weight lossprior to undergoing operative therapy: 55.7% (29) of AC and 61.9% (13) of SCC. There was a trend in patients with AC to have a BMI greater than 20, whilepatients with SCC tended to have a BMI less than 20 (<italic>P</italic> = .056). Thedifference in mean BMI among groups was significant, however. In the AC group,the mean was 26.7 while in the SCC group it was 22.889 (<italic>P</italic> = .0299). Also,female patients tended to have a decreased BMI (81.2%) versus male patients(36.7%); this was significant (<italic>P</italic> = .002) as well. The African-Americanpatients also had lower BMI (80% less than 20) than Caucasians (42.8% less than20; <italic>P</italic> = .06).</p><p>There were 65independently identified complications among 52 of the 73 patients comprisingthe cohort (<xref ref-type="table" rid="tab3">Table 3</xref>). Complications were graded on the basis of an establishedscale. Seventy percent of patients experienced some sort of complication: 9(12%) were grade 1, 12 (16%) were grade 2, 23 (31.5%) were grade 3, 1 (1%) was grade 4, and 6 (8%)were grade 5. The grade 5 complications included the three aforementioneddeaths. The rate of complications between the AC and SCC groups (65.4% versus85.7%) approached statistical significance (<italic>P</italic> = .0693). However, when thepatients with no complications were excluded, the distribution of the mostsevere complication in each patient (grade 1 or 2 versus grade 3, 4, or 5)revealed a statistically significant disproportion with more severecomplications occurring the SCC group versus the AC group (64.7% versus 55.9%, <italic>P</italic> = .0053). No difference existed among races or genders in complications. Pulmonarycomplications (including pneumonia) were the most predominant, comprising 29.3%of all complications. These were most strongly associated with prior cardiacdisease (<italic>P</italic> = .056), and not with prior COPD history (<italic>P</italic> = .225),pulmonary history (<italic>P</italic> = .336), histologic subtype (<italic>P</italic> = .503), orincreasing pack-year history of tobacco (<italic>P</italic> = .609). Esophageal leak (agrade 3 complication) was the second most common complication, with 10 (13.7%)occurrences. There was no significant difference in leak rate among histologicgroups (<italic>P</italic> = .805) or anastomosis type (<italic>P</italic> = .965).</p><p>Among the patients in the SCC group, themedian PNI was 40.95 (range 27.56 to 61.36); in the AC group the median was39.78 (range 27.75 to 57.16; <italic>P</italic> = .6983). PNI did not appear to affectmorbidity. In the group of patients with a PNI less than 40, there was acomplication rate of 70.83%; in those with a PNI greater than 40, the rate was79.17% (<italic>P</italic> = .5042). The distribution by grade of complications wasequivalent between those patients with a PNI of greater than 40 versus thosewith a PNI less than 40 (<italic>P</italic> = .9986). Patients with a PNI less than 40 were also not any more likely to have amajor (grade 3, 4, or 5) complication versus those with a PNI greater than 40 (<italic>P</italic> = .9396). The differences in distributions of pulmonary (<italic>P</italic> = .7452) and anastomoticleak (<italic>P</italic> = .1501) were also not statistically significant between the PNIgroups.</p><p>Despite the similarities among the groups intotal complications, SCC patients were more likely to have a 3-day or longerICU stay than AC patients (<italic>P</italic> = .004). The higher incidence of pulmonarydisease in these patients was the largest contributor to this finding (<italic>P</italic> = .0016). However, prior tobacco use (<italic>P</italic> = .8254), total pack years (<italic>P</italic> = .1286)or cardiac disease (<italic>P</italic> = .5803) were not associated with a prolonged ICUcourse. SCC was more likely in patients and 60 years of age (<italic>P</italic> = .004) butage was not an independent factor for prolonged ICU stay.</p></sec><sec sec-type="section" id="sec4"><title>4. Discussion</title><p>Advances in technique and patient care havelead to overall decreases in esophagectomy mortality in the last 5 years [<xref ref-type="bibr" rid="B8">8</xref>]. However, morbidity remains high (60% insome series) and appears to be associated with tumor histology. Thus the aim ofthe present study was to delineate the role of tumor histology in regards toperioperative morbidity and possibly preoperative decision making. Our studysuggests that tumor histology may be a significant predictor of morbidity,primarily as a surrogate for increased pulmonary complications. These findingsare supported by a similar study from the United Kingdom [<xref ref-type="bibr" rid="B9">9</xref>], and might function as an adjunct to otherprognostic scoring systems [<xref ref-type="bibr" rid="B10">10</xref>].</p><p>Despite advances in surgical technique andperioperative care, the types of complications in esophageal cancer are fairlyconsistent [<xref ref-type="bibr" rid="B11">11</xref>] (<xref ref-type="table" rid="tab4">Table 4</xref>). Pulmonary morbidity and anastomotic leaksremain the most common [<xref ref-type="bibr" rid="B12">12</xref>]; both of which can significantly effect apatient's long-term quality of life [<xref ref-type="bibr" rid="B13">13</xref>] when they occur. Pulmonary complicationscontribute to most cases of mortality in esophageal cancer and active effortsto minimize their effects have been attributed as one of the most significantcauses of decreased perioperative mortality [<xref ref-type="bibr" rid="B14">14</xref>]. The historically dreaded anastomotic leakhas been delegated to a lesser standing; this is in large part due to newminimally invasive endoscopic techniques that have been described for themanagement of leaks [<xref ref-type="bibr" rid="B15">15</xref>], making what was once a devastating problemsomewhat more easily managed and no longer a source of increased mortality ordecreased long-term survival [<xref ref-type="bibr" rid="B16">16</xref>]. However, the pulmonary problems are moredifficult in a population in which, at least in the case of SCC, patients aremore likely to be smokers and thus more likely to carry a diagnosis ofunderlying COPD. This was likely the root cause of the prolonged intensive careunit stays seen in the SCC cohort in this study.</p><p>The perioperative risks for patients withCOPD are well known [<xref ref-type="bibr" rid="B17">17</xref>]. However, age, operative duration, andproximal tumor location have also been identified as factors contributing topulmonary morbidity [<xref ref-type="bibr" rid="B18">18</xref>], of which all are more likely to beassociated with SCC histology than AC. Despite an efficient resection, patientswho suffer complications are at increased risk of surgical oncotaxis [<xref ref-type="bibr" rid="B19">19</xref>], the acceleration of their disease caused byoperative factors. The patients reported in this study by Hirai et al. hadearlier metastasis and poorer long-term outcomes. Therefore, at least from onestudy, minimizing morbidity is important not only from a short-termperioperative perspective but also from a long-term cancer prognosisstandpoint. Although it should be noted that another study, by Ferri et al.,showed an increased short-term mortality in SCC patients suffering a complication, there are no long-term effectsin those that survived [<xref ref-type="bibr" rid="B20">20</xref>].</p><p>Nutrition remains thefocus in many studies of esophagectomy, but its role in morbidity is somewhatunclear. Few other malignancies affect the nutritional status of the patientprior to diagnosis more than esophageal cancer, and are thus a potentialpowerful marker of surgical outcome. Most surgeons would associate esophagealcancer with malnutrition, noting the diminution in the ability of the patientto take in adequate calories in addition to the wasting normally seen withother malignancies, and thus try to supplement feedings. Advocates of thisapproach stress the benefits of preoperative enteral supplementation. Theperioperative advantages of this were identified in a paper by Nozoe demonstratingdecreased complications and better long-term survival in patients with higherprognostic nutritional index (PNI), a mathematical computation of the patientsalbumin and absolute lymphocyte count [<xref ref-type="bibr" rid="B21">21</xref>]. As discussed by Onodera in the initialdescription of PNI, a minimum value of 40 is recommended prior to undertakingan esophageal resection. In the present study, a PNI of less than 40 did notadversely affect outcomes and led to no increase in morbidity.</p><p>At the opposing end of the spectrum,increasing BMI has been attributed to the increasing incidence of AC. Evensignificantly, overweight patients may be relatively catabolic andconsideration for supplementation should be given in this population as well. Fortunately, increasing patient BMIs has not been associated with pooreroperative or disease related outcomes. Also, in at least one large study of 400patients, nutritional status as determined by BMI, PNI, weight loss, and other factorshad no value in predicting perioperative complications [<xref ref-type="bibr" rid="B22">22</xref>].</p><p>Over time, multimodality treatment ofesophageal cancer has improved, offering increased long-term survival [<xref ref-type="bibr" rid="B23">23</xref>]. Better results have been noted for factorsmost would identify as predictive of long-term success in any cancer, includinglow AJCC stage, R0 resection, and M0 status. Neoadjuvant therapy is gainingacceptance, as it can be given safely, is generally better tolerated thanadjuvant therapy, and does not affect operative morbidity or mortality. SCC can be treated safeand effectively with multimodality therapy, providing durable results even forpatients with positive nodal disease as well as those from Asian studiesdiscovered to have early tumors. Regardless of the physician's opinion in regardsto the timing of additional therapy, most agree that esophageal squamous andadenocarcinoma are not purely surgically treated diseases and that some form ofmultimodality treatment is needed to extend quality of life time. Therefore,from a surgical perspective, optimizing patient selection and operativetechnique are important so that patients may recover quickly and go on to theiradditional therapy.</p><p>Technical advances haveallowed for refinement in the techniques in esophageal surgery to reduceperioperative morbidity and mortality [<xref ref-type="bibr" rid="B24">24</xref>]. What technology to apply on a case-to-casebasis is a somewhat more difficult question to answer. Recent studies have alsoserved to benchmark expected courses for patients with AC, and the outcomes forall esophageal resections has improved significantly [<xref ref-type="bibr" rid="B25">25</xref>]. Because of this, any changes in techniquesor approach need to be critically reviewed. Choice of operative approach hasbeen extensively studied, but until recently has focused on the transhiatalversus transthoracic approach [<xref ref-type="bibr" rid="B2">2</xref>] or technical factors such as the location ofthe conduit in the mediastinum. With the public's growing interest in minimallyinvasive approaches, coupled with new techniques and instrumentation, minimallyinvasive esophagectomy has been proven safe and feasible both in the UnitedStates and abroad [<xref ref-type="bibr" rid="B3">3</xref>]. It also does not adversely affect long-termsurvival, a question that has been repeatedly raised when laparoscopicapproaches are used to address surgical oncology diagnoses. The difficulty isthat there are a variety of techniques and combinations of approaches reportedas &#x0201c;minimally invasive,&#x0201d; with no standardized definition and any real benefitover traditional techniques has yet to be proven. Most advocates of thisapproach perceive decreased pulmonary morbidities and improved pulmonarytherapy as the main advantages, but some studies have questioned this benefit. Preoperative pulmonary evaluations have tended to focus on pulmonary factorsalone, including smoking and COPD. However, given these factors in a high-risksubgroup (SCC), there might be more of an advantage for minimally invasivetechniques and perhaps we should evaluate these patients for this approach.</p><p>The limitations of thisstudy are the small sample size of the SCC patients. This limits the impact ofthe data presented, but does not limit the fact that these two types of histologies are bothbiologically different and physiologically different and treating physiciansshould be aware of these differences and the impact that these play onperioperative outcomes.</p></sec><sec sec-type="section" id="sec5"><title>5. Conclusion</title><p>The presence of SCC was the single bestpredictor of prolonged intensive care unit stay and more severe complicationsas defined by this study. Only a past history of pulmonary disease wasdifferent between the two histologic subgroups. No other factor, including sex,gender, age, or nutritional status was predictive of this outcome.  Esophageal histology should therefore beconsidered in the perioperative care of patients and may in the future be usedto guide operative strategies.</p></sec></body><back><ref-list><ref id="B1"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Atkins</surname><given-names>BZ</given-names></name><name><surname>D'Amico</surname><given-names>TA</given-names></name></person-group><article-title>Respiratory complications after esophagectomy</article-title><source><italic>Thoracic Surgery Clinics</italic></source><year>2006</year><volume>16</volume><issue>1</issue><fpage>35</fpage><lpage>48</lpage><pub-id pub-id-type="pmid">16696281</pub-id></citation></ref><ref id="B2"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hulscher</surname><given-names>JBF</given-names></name><name><surname>van Sandick</surname><given-names>JW</given-names></name><name><surname>de Boer</surname><given-names>AGEM</given-names></name><etal/></person-group><article-title>Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus</article-title><source><italic>The New England Journal of Medicine</italic></source><year>2002</year><volume>347</volume><issue>21</issue><fpage>1662</fpage><lpage>1669</lpage><pub-id pub-id-type="pmid">12444180</pub-id></citation></ref><ref id="B3"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Luketich</surname><given-names>JD</given-names></name><name><surname>Alvelo-Rivera</surname><given-names>M</given-names></name><name><surname>Buenaventura</surname><given-names>PO</given-names></name><etal/></person-group><article-title>Minimally invasive esophagectomy: outcomes in 222 patients</article-title><source><italic>Annals of Surgery</italic></source><year>2003</year><volume>238</volume><issue>4</issue><fpage>486</fpage><lpage>495</lpage><pub-id pub-id-type="pmid">14530720</pub-id></citation></ref><ref id="B4"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Delgado Gomis</surname><given-names>F</given-names></name><name><surname>G&#x000f3;mez Abril</surname><given-names>SA</given-names></name><name><surname>Manuel</surname><given-names>M</given-names></name><name><surname>Guallar Rovira</surname><given-names>JM</given-names></name></person-group><article-title>Assisted laparoscopic transhiatal esophagectomy for the treatment of esophageal cancer</article-title><source><italic>Clinical and Translational Oncology</italic></source><year>2006</year><volume>8</volume><issue>3</issue><fpage>185</fpage><lpage>192</lpage><pub-id pub-id-type="pmid">16648118</pub-id></citation></ref><ref id="B5"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alexiou</surname><given-names>C</given-names></name><name><surname>Khan</surname><given-names>OA</given-names></name><name><surname>Black</surname><given-names>E</given-names></name><etal/></person-group><article-title>Survival after esophageal resection for carcinoma: the importance of the histologic cell type</article-title><source><italic>Annals of Thoracic Surgery</italic></source><year>2006</year><volume>82</volume><issue>3</issue><fpage>1073</fpage><lpage>1077</lpage><pub-id pub-id-type="pmid">16928541</pub-id></citation></ref><ref id="B6"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Onodera</surname><given-names>T</given-names></name><name><surname>Goseki</surname><given-names>N</given-names></name><name><surname>Kosaki</surname><given-names>G</given-names></name></person-group><article-title>Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients</article-title><source><italic>Nippon Geka Gakkai Zasshi</italic></source><year>1984</year><volume>85</volume><issue>9</issue><fpage>1001</fpage><lpage>1005</lpage><pub-id pub-id-type="pmid">6438478</pub-id></citation></ref><ref id="B7"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>RC</given-names><suffix>II</suffix></name><name><surname>Jaques</surname><given-names>DP</given-names></name><name><surname>Brennan</surname><given-names>MF</given-names></name><name><surname>Karpeh</surname><given-names>M</given-names></name></person-group><article-title>Achieving R0 resection for locally advanced gastric cancer: is it worth the risk of multiorgan resection?</article-title><source><italic>Journal of the American College of Surgeons</italic></source><year>2002</year><volume>194</volume><issue>5</issue><fpage>568</fpage><lpage>577</lpage><pub-id pub-id-type="pmid">12025834</pub-id></citation></ref><ref id="B8"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dimick</surname><given-names>JB</given-names></name><name><surname>Wainess</surname><given-names>RM</given-names></name><name><surname>Upchurch</surname><given-names>GR</given-names><suffix>Jr.</suffix></name><name><surname>Iannettoni</surname><given-names>MD</given-names></name><name><surname>Orringer</surname><given-names>MB</given-names></name></person-group><article-title>National trends in outcomes for esophageal resection</article-title><source><italic>Annals of Thoracic Surgery</italic></source><year>2005</year><volume>79</volume><issue>1</issue><fpage>212</fpage><lpage>216</lpage><pub-id pub-id-type="pmid">15620945</pub-id></citation></ref><ref id="B9"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alexiou</surname><given-names>C</given-names></name><name><surname>Khan</surname><given-names>OA</given-names></name><name><surname>Black</surname><given-names>E</given-names></name></person-group><article-title>Survival after esophageal resection for carcinoma: the importance of the histologic cell type</article-title><source><italic>Annals of Thoracic Surgery</italic></source><year>2006</year><volume>82</volume><issue>3</issue><fpage>1073</fpage><lpage>1077</lpage><pub-id pub-id-type="pmid">16928541</pub-id></citation></ref><ref id="B10"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ferguson</surname><given-names>MK</given-names></name><name><surname>Durkin</surname><given-names>AE</given-names></name></person-group><article-title>Preoperative prediction of the risk of pulmonary complications after esophagectomy for cancer</article-title><source><italic>Journal of Thoracic and Cardiovascular Surgery</italic></source><year>2002</year><volume>123</volume><issue>4</issue><fpage>661</fpage><lpage>669</lpage><pub-id pub-id-type="pmid">11986593</pub-id></citation></ref><ref id="B11"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Griffin</surname><given-names>SM</given-names></name><name><surname>Shaw</surname><given-names>IH</given-names></name><name><surname>Dresner</surname><given-names>SM</given-names></name></person-group><article-title>Early complications after Ivor Lewis subtotal esophagectomy with two-field lymphadenectomy: risk factors and management</article-title><source><italic>Journal of the American College of Surgeons</italic></source><year>2002</year><volume>194</volume><issue>3</issue><fpage>285</fpage><lpage>297</lpage><pub-id pub-id-type="pmid">11893132</pub-id></citation></ref><ref id="B12"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Urschel</surname><given-names>JD</given-names></name></person-group><article-title>Esophagogastrostomy anastomotic leaks complicating esophagectomy: a review</article-title><source><italic>American Journal of Surgery</italic></source><year>1995</year><volume>169</volume><issue>6</issue><fpage>634</fpage><lpage>640</lpage><pub-id pub-id-type="pmid">7771633</pub-id></citation></ref><ref id="B13"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Viklund</surname><given-names>P</given-names></name><name><surname>Lindblad</surname><given-names>M</given-names></name><name><surname>Lagergren</surname><given-names>J</given-names></name></person-group><article-title>Influence of surgery-related factors on quality of life after esophageal or cardia cancer resection</article-title><source><italic>World Journal of Surgery</italic></source><year>2005</year><volume>29</volume><issue>7</issue><fpage>841</fpage><lpage>848</lpage><pub-id pub-id-type="pmid">15951920</pub-id></citation></ref><ref id="B14"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Atkins</surname><given-names>BZ</given-names></name><name><surname>D'Amico</surname><given-names>TA</given-names></name></person-group><article-title>Respiratory complications after esophagectomy</article-title><source><italic>Thoracic Surgery Clinics</italic></source><year>2006</year><volume>16</volume><issue>1</issue><fpage>35</fpage><lpage>48</lpage><pub-id pub-id-type="pmid">16696281</pub-id></citation></ref><ref id="B15"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schubert</surname><given-names>D</given-names></name><name><surname>Pross</surname><given-names>M</given-names></name><name><surname>Nestler</surname><given-names>G</given-names></name><etal/></person-group><article-title>Endoscopic treatment of mediastinal anastomotic leaks</article-title><source><italic>Zentralblatt f&#x000fc;r Chirurgie</italic></source><year>2006</year><volume>131</volume><issue>5</issue><fpage>369</fpage><lpage>375</lpage></citation></ref><ref id="B16"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>LW</given-names></name><name><surname>Swisher</surname><given-names>SG</given-names></name><name><surname>Hofstetter</surname><given-names>W</given-names></name><etal/></person-group><article-title>Intrathoracic leaks following esophagectomy are no longer associated with increased mortality</article-title><source><italic>Annals of Surgery</italic></source><year>2005</year><volume>242</volume><issue>3</issue><fpage>392</fpage><lpage>402</lpage><pub-id pub-id-type="pmid">16135925</pub-id></citation></ref><ref id="B17"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jiao</surname><given-names>W-J</given-names></name><name><surname>Wang</surname><given-names>T-Y</given-names></name><name><surname>Gong</surname><given-names>M</given-names></name><name><surname>Pan</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>YB</given-names></name><name><surname>Liu</surname><given-names>ZH</given-names></name></person-group><article-title>Pulmonary complications in patients with chronic obstructive pulmonary disease following transthoracic esophagectomy</article-title><source><italic>World Journal of Gastroenterology</italic></source><year>2006</year><volume>12</volume><issue>16</issue><fpage>2505</fpage><lpage>2509</lpage><pub-id pub-id-type="pmid">16688794</pub-id></citation></ref><ref id="B18"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Law</surname><given-names>S</given-names></name><name><surname>Wong</surname><given-names>K-H</given-names></name><name><surname>Kwok</surname><given-names>K-F</given-names></name><name><surname>Chu</surname><given-names>K-M</given-names></name><name><surname>Wong</surname><given-names>J</given-names></name></person-group><article-title>Predictive factors for postoperative pulmonary complications and mortality after esophagectomy for cancer</article-title><source><italic>Annals of Surgery</italic></source><year>2004</year><volume>240</volume><issue>5</issue><fpage>791</fpage><lpage>800</lpage><pub-id pub-id-type="pmid">15492560</pub-id></citation></ref><ref id="B19"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hirai</surname><given-names>T</given-names></name><name><surname>Matsumoto</surname><given-names>H</given-names></name><name><surname>Yamashita</surname><given-names>K</given-names></name><etal/></person-group><article-title>Surgical oncotaxis&#x02013;excessive surgical stress and postoperative complications contribute to enhancing tumor metastasis, resulting in a poor prognosis for cancer patients</article-title><source><italic>Annals of Ahoracic and Cardiovascular Surgery</italic></source><year>2005</year><volume>11</volume><issue>1</issue><fpage>4</fpage><lpage>6</lpage></citation></ref><ref id="B20"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ferri</surname><given-names>LE</given-names></name><name><surname>Law</surname><given-names>S</given-names></name><name><surname>Wong</surname><given-names>K-H</given-names></name><name><surname>Kwok</surname><given-names>K-F</given-names></name><name><surname>Wong</surname><given-names>J</given-names></name></person-group><article-title>The influence of technical complications on postoperative outcome and survival after esophagectomy</article-title><source><italic>Annals of Surgical Oncology</italic></source><year>2006</year><volume>13</volume><issue>4</issue><fpage>557</fpage><lpage>564</lpage><pub-id pub-id-type="pmid">16485146</pub-id></citation></ref><ref id="B21"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nozoe</surname><given-names>T</given-names></name><name><surname>Kimura</surname><given-names>Y</given-names></name><name><surname>Ishida</surname><given-names>M</given-names></name><name><surname>Saeki</surname><given-names>H</given-names></name><name><surname>Korenaga</surname><given-names>D</given-names></name><name><surname>Sugimachi</surname><given-names>K</given-names></name></person-group><article-title>Correlation of pre-operative nutritional condition with post-operative complications in surgical treatment for oesophageal carcinoma</article-title><source><italic>European Journal of Surgical Oncology</italic></source><year>2002</year><volume>28</volume><issue>4</issue><fpage>396</fpage><lpage>400</lpage><pub-id pub-id-type="pmid">12099649</pub-id></citation></ref><ref id="B22"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Han-Geurts</surname><given-names>IJM</given-names></name><name><surname>Hop</surname><given-names>WC</given-names></name><name><surname>Tran</surname><given-names>TCK</given-names></name><name><surname>Tilanus</surname><given-names>HW</given-names></name></person-group><article-title>Nutritional status as a risk factor in esophageal surgery</article-title><source><italic>Digestive Surgery</italic></source><year>2006</year><volume>23</volume><issue>3</issue><fpage>159</fpage><lpage>163</lpage><pub-id pub-id-type="pmid">16888387</pub-id></citation></ref><ref id="B23"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hofstetter</surname><given-names>W</given-names></name><name><surname>Swisher</surname><given-names>SG</given-names></name><name><surname>Correa</surname><given-names>AM</given-names></name><etal/></person-group><article-title>Treatment outcomes of resected esophageal cancer</article-title><source><italic>Annals of Surgery</italic></source><year>2002</year><volume>236</volume><issue>3</issue><fpage>376</fpage><lpage>385</lpage><pub-id pub-id-type="pmid">12192324</pub-id></citation></ref><ref id="B24"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dionigi</surname><given-names>G</given-names></name><name><surname>Rovera</surname><given-names>F</given-names></name><name><surname>Boni</surname><given-names>L</given-names></name><name><surname>Carrafiello</surname><given-names>G</given-names></name><name><surname>Mangini</surname><given-names>M</given-names></name><name><surname>Dionigi</surname><given-names>R</given-names></name></person-group><article-title>The surgeon's approach to preoperative evaluation of esophageal cancer: recent developments</article-title><source><italic>Rays</italic></source><year>2005</year><volume>30</volume><issue>4</issue><fpage>351</fpage><lpage>356</lpage><pub-id pub-id-type="pmid">16792013</pub-id></citation></ref><ref id="B25"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mariette</surname><given-names>C</given-names></name><name><surname>Taillier</surname><given-names>G</given-names></name><name><surname>Van Seuningen</surname><given-names>I</given-names></name><name><surname>Triboulet</surname><given-names>J-P</given-names></name></person-group><article-title>Factors affecting postoperative course and survival after en bloc resection for esophageal carcinoma</article-title><source><italic>Annals of Thoracic Surgery</italic></source><year>2004</year><volume>78</volume><issue>4</issue><fpage>1177</fpage><lpage>1183</lpage><pub-id pub-id-type="pmid">15464466</pub-id></citation></ref></ref-list></back><floats-wrap><table-wrap id="tab1" position="float"><label>Table 1</label><caption><p>Adenocarcinoma and squamous cell carcinoma groups patient demographics.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">Adenocarcinoma, <italic>n</italic> (%)</th><th align="center" rowspan="1" colspan="1">Squamous cell carcinoma, <italic>n</italic> (%)</th><th align="center" rowspan="1" colspan="1"><italic>P</italic>-value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><italic>n</italic></td><td align="center" rowspan="1" colspan="1">52 (71%)</td><td align="center" rowspan="1" colspan="1">21 (29%)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Median age</td><td align="center" rowspan="1" colspan="1">59</td><td align="center" rowspan="1" colspan="1">63</td><td align="center" rowspan="1" colspan="1">.21</td></tr><tr><td align="left" rowspan="1" colspan="1">Caucasian race</td><td align="center" rowspan="1" colspan="1">44 (8462%)</td><td align="center" rowspan="1" colspan="1">10 (47.62%)</td><td align="center" rowspan="1" colspan="1"><bold>.0004</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">Male gender</td><td align="center" rowspan="1" colspan="1">45 (86.54%)</td><td align="center" rowspan="1" colspan="1">10 (47.62%)</td><td align="center" rowspan="1" colspan="1"><bold>.0007</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">Alcohol abuse</td><td align="center" rowspan="1" colspan="1">6 (11.54%)</td><td align="center" rowspan="1" colspan="1">8 (38.1%)</td><td align="center" rowspan="1" colspan="1"><bold>.012</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">Tobacco use</td><td align="center" rowspan="1" colspan="1">36 (69.23%)</td><td align="center" rowspan="1" colspan="1">13 (61.9%)</td><td align="center" rowspan="1" colspan="1">.5492</td></tr><tr><td align="left" rowspan="1" colspan="1">Prior cardiac disease</td><td align="center" rowspan="1" colspan="1">13 (25%)</td><td align="center" rowspan="1" colspan="1">4 (19.05%)</td><td align="center" rowspan="1" colspan="1">.573</td></tr><tr><td align="left" rowspan="1" colspan="1">Prior pulmonary disease</td><td align="center" rowspan="1" colspan="1">3 (5.77%)</td><td align="center" rowspan="1" colspan="1">5 (23.81%)</td><td align="center" rowspan="1" colspan="1"><bold>.034</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">FEV1  &#x0003c;75%</td><td align="center" rowspan="1" colspan="1">3 (5.77%)</td><td align="center" rowspan="1" colspan="1">4 (19%)</td><td align="center" rowspan="1" colspan="1">.06</td></tr></tbody></table></table-wrap><table-wrap id="tab2" position="float"><label>Table 2</label><caption><p>Adenocarcinoma and squamouscell carcinoma tumor features and perioperative data.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">Adenocarcinoma, <italic>n</italic> (%)</th><th align="center" rowspan="1" colspan="1">Squamous cell carcinoma, <italic>n</italic> (%)</th><th align="center" rowspan="1" colspan="1"><italic>P</italic>-value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">T stage</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">.2032</td></tr><tr><td align="center" colspan="5" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">T0</td><td align="center" rowspan="1" colspan="1">5 (9.80%)</td><td align="center" rowspan="1" colspan="1">2 (9.52%)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">Tis</td><td align="center" rowspan="1" colspan="1">2 (3.92%)</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">T1</td><td align="center" rowspan="1" colspan="1">5 (9.80%)</td><td align="center" rowspan="1" colspan="1">4 (19.05%)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">T2</td><td align="center" rowspan="1" colspan="1">10 (19.61%)</td><td align="center" rowspan="1" colspan="1">2 (9.52%)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"> T3 </td><td align="center" rowspan="1" colspan="1">27 (52.94%)</td><td align="center" rowspan="1" colspan="1">9 (42.86%)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"> T4 </td><td align="center" rowspan="1" colspan="1">2 (3.92%)</td><td align="center" rowspan="1" colspan="1">4 (19.05%)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="center" colspan="5" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1"> N stage </td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">.1933</td></tr><tr><td align="center" colspan="5" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"> N0 </td><td align="center" rowspan="1" colspan="1">24 (47.06%)</td><td align="center" rowspan="1" colspan="1">14 (66.67%)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"> N1 </td><td align="center" rowspan="1" colspan="1">25 (49.02%)</td><td align="center" rowspan="1" colspan="1">7 (33.33%)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"> N2 </td><td align="center" rowspan="1" colspan="1">2 (3.92%)</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="center" colspan="5" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1"> Neoadjuvant therapy </td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">18 (34.62%)</td><td align="center" rowspan="1" colspan="1">9 (42.86%)</td><td align="center" rowspan="1" colspan="1">.5114</td></tr><tr><td align="left" rowspan="1" colspan="1"> Weight loss </td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">29 (55.77%)</td><td align="center" rowspan="1" colspan="1">13 (61.90%)</td><td align="center" rowspan="1" colspan="1">.6301</td></tr><tr><td align="left" rowspan="1" colspan="1"> Mean BMI </td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">26.72</td><td align="center" rowspan="1" colspan="1">22.89</td><td align="center" rowspan="1" colspan="1"><bold>.0299</bold></td></tr><tr><td align="left" rowspan="1" colspan="1"> Mean PNI </td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">33.61</td><td align="center" rowspan="1" colspan="1">33.00</td><td align="center" rowspan="1" colspan="1">.6921</td></tr><tr><td align="left" rowspan="1" colspan="1"> Epidural anesthesia </td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">44 (85%)</td><td align="center" rowspan="1" colspan="1">18 (87%)</td><td align="center" rowspan="1" colspan="1">.78</td></tr><tr><td align="center" colspan="5" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1"> Anastomosis </td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">.8892</td></tr><tr><td align="center" colspan="5" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"> Stapled </td><td align="center" rowspan="1" colspan="1">17 (33.33%)</td><td align="center" rowspan="1" colspan="1">6 (31.58%)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"> Sewn </td><td align="center" rowspan="1" colspan="1">34 (66.67%)</td><td align="center" rowspan="1" colspan="1">13 (68.42%)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"> Mean EBL </td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">551.065</td><td align="center" rowspan="1" colspan="1">600.000</td><td align="center" rowspan="1" colspan="1">.7626</td></tr><tr><td align="left" rowspan="1" colspan="1"> Margin Pos </td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">1 (2%)</td><td align="center" rowspan="1" colspan="1">1 (4%)</td><td align="center" rowspan="1" colspan="1">.08</td></tr><tr><td align="left" rowspan="1" colspan="1"> Time from OP to extubation </td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0.5 (0&#x02013;48)</td><td align="center" rowspan="1" colspan="1">1 (0&#x02013;72)</td><td align="center" rowspan="1" colspan="1">.86</td></tr><tr><td align="left" rowspan="1" colspan="1"> Complications </td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">34 (65.38%)</td><td align="center" rowspan="1" colspan="1">18 (85.71%)</td><td align="center" rowspan="1" colspan="1">.0693</td></tr><tr><td align="center" colspan="5" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1"> Grade of complications </td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"><bold>.0053</bold></td></tr><tr><td align="center" colspan="5" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"> 1 or 2 </td><td align="center" rowspan="1" colspan="1">15 (44.12%)</td><td align="center" rowspan="1" colspan="1">6 (35.29%)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"> 3, 4, or 5 </td><td align="center" rowspan="1" colspan="1">19 (55.88%)</td><td align="center" rowspan="1" colspan="1">11 (64.71%)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"> ICU stay  &#x0003e;3 days </td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">23 (47.92%)</td><td align="center" rowspan="1" colspan="1">16 (76.19%)</td><td align="center" rowspan="1" colspan="1"><bold>.0259</bold></td></tr></tbody></table></table-wrap><table-wrap id="tab3" position="float"><label>Table 3</label><caption><p>All inhospital and 90-day postoperative complications and grade by histology.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Complication</th><th align="center" rowspan="1" colspan="1">Adeno</th><th align="center" rowspan="1" colspan="1">SCC</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><italic>n</italic></td><td align="center" rowspan="1" colspan="1">34/52 (65%)</td><td align="center" rowspan="1" colspan="1">17/21 (81%)</td></tr><tr><td align="center" colspan="3" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Grade 1:</td><td align="center" rowspan="1" colspan="1"><bold>6</bold></td><td align="center" rowspan="1" colspan="1"><bold>3</bold></td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>&#x02003;</italic>Pneumonia</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>&#x02003;</italic>Fever</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>&#x02003;</italic>Partial cord paralysis</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>&#x02003;</italic>Anastomotic leak</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>&#x02003;</italic>Hypertension</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>&#x02003;</italic>Decubitus ulcer</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>&#x02003;</italic>Hypovolemia</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>&#x02003;</italic>Urinary tract infection</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="center" colspan="3" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Grade 2:</td><td align="center" rowspan="1" colspan="1"><bold>9</bold></td><td align="center" rowspan="1" colspan="1"><bold>3</bold></td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>&#x02003;</italic>Fever</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>&#x02003;</italic>Mediastinitis</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>&#x02003;</italic>Prolonged enteral feeding</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>&#x02003;</italic>Excessive pain</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>&#x02003;</italic>Pneumonia</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>&#x02003;</italic>Pleural effusion</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>&#x02003;</italic>Readmission</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>&#x02003;</italic>Anastomotic leak</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>&#x02003;</italic>Atrial fibrillation</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="center" colspan="3" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Grade 3:</td><td align="center" rowspan="1" colspan="1"><bold>15</bold></td><td align="center" rowspan="1" colspan="1"><bold>8</bold></td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>&#x02003;</italic>Pleural effusion, pneumonia</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>&#x02003;</italic>Anastomotic leak, EtOH withdrawal</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>&#x02003;</italic>Anastomotic leak, pleural effusion</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>&#x02003;</italic>Anastomotic leak</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>&#x02003;</italic>Delayed gastric emptying</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>&#x02003;</italic>Pleural effusion</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>&#x02003;</italic>Respiratory compromise</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>&#x02003;</italic>Confusion, esophageal leak</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>&#x02003;</italic>Confusion, pneumonia, respiratory failure</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>&#x02003;</italic>Pleural effusion, atelectasis</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>&#x02003;</italic>Anastomotic leak, pneumonia</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>&#x02003;</italic>Anastomotic leak, pneumonia, SVT</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>&#x02003;</italic>Anastomotic leak, evisceration</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>&#x02003;</italic>Anastomotic leak, paraesophageal hernia</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>&#x02003;</italic>SVT</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>&#x02003;</italic>Pneumonia</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>&#x02003;</italic>Hemorrhage</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="center" colspan="3" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Grade 4:</td><td align="center" rowspan="1" colspan="1"><bold>1</bold></td><td align="center" rowspan="1" colspan="1"><bold>0</bold></td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>&#x02003;</italic>Anastomotic leak</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="center" colspan="3" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Grade 5:</td><td align="center" rowspan="1" colspan="1"><bold>3</bold></td><td align="center" rowspan="1" colspan="1"><bold>3</bold></td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>&#x02003;</italic>Anastomotic leak</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>&#x02003;</italic>Pneumonia</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>&#x02003;</italic>Pulmonary embolus</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>&#x02003;</italic>Death</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">1</td></tr></tbody></table></table-wrap><table-wrap id="tab4" position="float"><label>Table 4</label><caption><p>Recent studies of morbidity in SCC patients undergoing esophagectomy.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Author</th><th align="center" rowspan="1" colspan="1">Year</th><th align="center" rowspan="1" colspan="1"><italic>n</italic></th><th align="center" rowspan="1" colspan="1">SCC %</th><th align="center" rowspan="1" colspan="1">SCC approach</th><th align="center" rowspan="1" colspan="1">SCC pulmonary</th><th align="center" rowspan="1" colspan="1">SCC anastomotic leak</th><th align="center" rowspan="1" colspan="1">SCC median EBL (mL)</th><th align="center" rowspan="1" colspan="1">SCC ICU stay (days)</th><th align="center" rowspan="1" colspan="1">SCC mortality</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Whooley</td><td align="center" rowspan="1" colspan="1">2001</td><td align="center" rowspan="1" colspan="1">710</td><td align="center" rowspan="1" colspan="1">100%</td><td align="center" rowspan="1" colspan="1">TTE (100%)</td><td align="center" rowspan="1" colspan="1">32%</td><td align="center" rowspan="1" colspan="1">3.5%</td><td align="center" rowspan="1" colspan="1">832</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">11%</td></tr><tr><td align="left" rowspan="1" colspan="1">Ferguson</td><td align="center" rowspan="1" colspan="1">2002</td><td align="center" rowspan="1" colspan="1">290</td><td align="center" rowspan="1" colspan="1">34.5%</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">39%</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" rowspan="1" colspan="1">Fang</td><td align="center" rowspan="1" colspan="1">2003</td><td align="center" rowspan="1" colspan="1">441</td><td align="center" rowspan="1" colspan="1"> &#x0003e;90%</td><td align="center" rowspan="1" colspan="1">3 Field (100%)</td><td align="center" rowspan="1" colspan="1">7.3%</td><td align="center" rowspan="1" colspan="1">32.65%</td><td align="center" rowspan="1" colspan="1">587.5&#x02013;642.1</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">2.5%</td></tr><tr><td align="left" rowspan="1" colspan="1">Law</td><td align="center" rowspan="1" colspan="1">2004</td><td align="center" rowspan="1" colspan="1">421</td><td align="center" rowspan="1" colspan="1">100%</td><td align="center" rowspan="1" colspan="1">TTE (83%)</td><td align="center" rowspan="1" colspan="1">15.9%</td><td align="center" rowspan="1" colspan="1">3.1%</td><td align="center" rowspan="1" colspan="1">700</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">1.4%</td></tr><tr><td align="left" rowspan="1" colspan="1">Alexiou</td><td align="center" rowspan="1" colspan="1">2006</td><td align="center" rowspan="1" colspan="1">621</td><td align="center" rowspan="1" colspan="1">31.72%</td><td align="center" rowspan="1" colspan="1">TTE (55%)</td><td align="center" rowspan="1" colspan="1">18.3%</td><td align="center" rowspan="1" colspan="1">8.6%</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">8.1%</td></tr><tr><td align="left" rowspan="1" colspan="1">Woodall</td><td align="center" rowspan="1" colspan="1">2007</td><td align="center" rowspan="1" colspan="1">73</td><td align="center" rowspan="1" colspan="1">29%</td><td align="center" rowspan="1" colspan="1">TTE (100%)</td><td align="center" rowspan="1" colspan="1">28.57%</td><td align="center" rowspan="1" colspan="1">26.32%</td><td align="center" rowspan="1" colspan="1">600</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">0%</td></tr></tbody></table></table-wrap></floats-wrap></article>